Two wild weeks for Grail end in $8B Illumina buyout

Grail’s whirlwind two weeks have ended in the wealthy arms of its former founder and benefactors. Illumina has shelled out $8 billion to reacquire the closely-watched liquid biopsy startup they spun out just 5 years ago and sold off much of its shares just 3 years ago. The deal comes…

Click to view original post

Advertise With Us